Summary To clarify the relation between bcl-2 and bax protein (Bcl-2 and Bax) expression with regard to apoptosis and cell proliferation, 82 gastric carcinomas were immunohistochemically investigated. The significance of apoptosis for biological behaviour of the tumours was also examined. The apoptotic indices (Als) were significantly lower in early-stage than in advanced-stage lesions (P<0.05), being positively correlated with the mitotic indices (MIs) (r=0.447, P<0.001). No association between either Als or Mls and tumour size (diameter of intramural spreading) was noted. The Als in the high Bcl-2-immunoreactive score group were significantly smaller than in either the low or the negative categories, whereas they were relatively elevated in the high Bax score group. In addition, an inverse correlation between Bcl-2 and Bax expression was revealed for both Als and MIs. Although depth of tumour invasion and lymph node status were clearly associated with favourable outcome, no relation between survival rates and average values of either Als or MIs, or immunoreactive scores for Bcl-2 and Bax was observed. These results indicate that in gastric carcinomas, apoptosis is closely associated with cell proliferation and expression of Bcl-2 and Bax, but appears likely to have no particular biological significance as a prognostic factor.
Analysis of the balance between cell proliferation and loss by death is essential for assessment of tissue kinetics. It is widely accepted that apoptosis, with its characteristic nuclear and cytoplasmic features, plays an important role in cell deletion, especially during embryogenesis. For example, naturally occurring neuronal death during neurogenesis and negative selection of T lymphocytes in the thymus are achieved by apoptosis (Shi et al, 1989; Smith et al, 1989) . Recently, several studies have documented a possible role of apoptosis in the development or progression of malignant neoplasms, including cervical (Shoji et al, 1996) , oesophageal (Ohbu et al, 1995) and colorectal tumours (Ikenaga et al, 1996) . Our previous study demonstrated a close correlation between the susceptibility to apoptosis and either depth of tumour invasion or histological differentiation in gastric carcinomas (Saegusa et al, 1995a) . However the significance of apoptosis in clinicopathological behaviour (as a prognostic factor) still remains to be determined.
The bcl-2 proto-oncogene, discovered at the t(14;18) chromosomal breakpoint in human follicular lymphomas and B-cell leukaemias, is a member of the group of molecules related to apoptosis, its expression being able to inhibit the process of this form of single-cell death (Tsujimoto et al, 1984) . It has been proposed that there is a new category of oncogenes, linked to the bcl-2 gene as extended cell survival, [suppression of apoptosis due to bcl-2 protein (Bcl-2) expression] may prove to be a key event that increases the opportunity to acquire additional genetic defects in proliferation-associated or tumour-suppressor genes contrast, has been demonstrated to accelerate cell death after an apoptotic stimulus, by forming heterodimers with Bcl-2 (Krajiewski et al, 1994) . Little is known of the relationship between Bcl-2 and Bax expression in human malignant tumours and therefore, in the present study, we investigated this point and its significance for apoptosis and cell proliferation in a series of human gastric carcinomas. In addition, the clinicopathological relevance of apoptosis to biological behaviour was examined.
MATERIALS AND METHODS Cases
A total of 82 gastric carcinoma cases surgically resected at the Kitasato University Hospital during 1988 to 1994 were investigated. All the tissues were fixed in 10% buffered formalin and embedded in paraffin wax. Histopathological assessment was performed according to the criteria of Sugano et al (1982) : welldifferentiated and moderately differentiated adenocarcinomas were included in the differentiated category and poorly differentiated adenocarcinomas and signet-ring cell carcinomas were in the undifferentiated type. With this classification, the investigated series comprised 58 cases of the differentiated type and 24 of the undifferentiated type. Both types were subclassified into two groups according to the depth of invasion, 40 cases of early-stage lesions demonstrating invasion of the mucosa and/or submucosa and 42 cases of advanced stage exhibiting invasion into or through the muscularis propria.
Of 82 gastric carcinomas, we were able to analyse 78 cases for outcome after surgery with a mean follow-up time of 30 months (range 1-93 months). None of the cases had been treated by chemotherapy or radiotherapy before gastrectomy. Sixty-four 
Statistics
To analyse the correlation among AIs, MIs and Bcl-2 and Bax immunoreactivity in gastric carcinomas, the Mann-Whitney Utest and the Pearson's correlation coefficient were used, considering pathological factors, including tumour differentiation, depth of invasion and size (lateral spreading diameter). Survival was measured from the time of primary operation and survival curves were generated by the methods of Kaplan and Meier (1958) . The log-rank test and Cox proportional hazards modelling were performed to compare survival rates between subgroups classified for various factors, including tumour stage, lymph node status, AIs, MIs and Bcl-2 and Bax immunoreactivity. In addition, relation to lymph node status with or without Bcl-2 or Bax positivity was analysed by the chi-square linear test. The cut-off for statistical significance was defined as P <0.05.
British Journal of Cancer (1997) frequently associated with severe inflammation and necrosis, while being rare in normal gastric epithelium. Although differentiation between apoptotic cells and small lymphocytes infiltrating the tumour lesions was occasionally difficult, a chromatin pattern was generally discernible in the latter and their scant cytoplasm was useful for distinguishing them from apoptotic cells as described previously (Aihara et al, 1994) .
0.95 ± 0.4 and 1.16 ± 0.33% respectively. The values for earlystage and differentiated-type lesions were statistically lower than for the advanced and undifferentiated categories (Figure 2 , P <0.05 respectively).
Pearson's correlation coefficient analysis revealed a close correlation between AIs and MIs ( Figure 3A , r =0.447, P <0.001), but there was no association between either AIs or MIs and tumour size (lateral spreading diameter) ( Figure 3B ).
Relation between Als and Mis
The AIs of early-or advanced-stage carcinomas and differentiated or undifferentiated types were 1.12 ± 0.45% (mean ± s.d.), 1.28 + 0.33%, 1.18 ± 0.42% and 1.26 ± 0.33% respectively. The earlystage value was significantly lower than that for advanced-stage lesions (P <0.05), whereas no correlation with tumour differentiation was found (Figure 2) .
The MIs for early-or advanced-stage carcinomas and differentiated or undifferentiated types were 0.92 ± 0.42%, 1.09 ± 0.34%, Relation among Als, MIs and expression of BcI-2 and Bax Bcl-2 immunoreactivity was found throughout the cytoplasm, with some concentration in the perinuclear zone, in tumour cells. The intensity of immunostaining and the distribution of positive cells were heterogeneous ( Figure 4F ). Figure 5B , P =0.053, P <0.05 respectively), whereas no association was noted on the basis of tumour-stage category, including early and advanced stages. The finding for correlations among AIs, MIs and immunopositivity for Bcl-2 and Bax are summarized in Figure SC . An inverse correlation regarding AIs and MIs between Bcl-2 and Bax positivity was noted, the difference being significant (P <0.05, P <0.05 respectively). Thus Al and MI values were low in Bcl-2 strong positive cases whereas they were high in lesions demonstrating Bax British Journal of Cancer (1997) immunoreactivity. However, there were no significant differences in AIs and MIs between the group expressing one or the other of the two immunohistochemical parameters and the group positive for both ( Figure 5C ).
Survival
An early stage (36 early vs 42 advanced stage, P <0.01) and an absence of lymph node metastasis (32 negative vs 46 positive groups, P <0.01) were clearly associated with favourable outcome (data not shown). However, there was no association between survival rates and classification in terms of average values for either AIs or MIs, immunoreactive scores for either Bcl-2 or Bax or chemotherapy. Moreover, no correlation between lymph node status and AIs, MIs or immunopositivity for Bcl-2 and Bax was noted, with analysis of either all lesions or only advanced cases (Table 1) .
DISCUSSION
It is widely accepted that cells with a high proliferation activity or after withdrawal of trophic hormone stimulation in terminal differentiated cases are very susceptible to apoptosis (Allan et al, 1987; Ijiri et al, 1987; Walker et al, 1989) . Strater et al (1995) reported enterocytes undergoing apoptosis to be found frequently in the proliferating zones and luminal surface mucosae in normal colorectal epithelium. In colorectal adenomas, a clear positive correlation between apoptotic and mitotic indices has been demonstrated (Arai et al, 1995) . In the present study, the AIs were closely associated with the depth of tumour invasion in gastric carcinomas, in line with the results of our previous report using the in situ DNA nick end labelling method (Saegusa et al, 1995a) , but showed no statistically significant relation to tumour differentiation in contrast to the MI values. This study further demonstrated a positive correlation between AIs and cell proliferation determined by the MI, whereas no linkage between either of these indices and the tumour size (lateral spreading diameter) was noted in early or advanced stages. It is therefore suggested that tumour invasion through the mucosa to the serosa may be more closely linked to increased cell proliferative activity and propensity for apoptosis than lateral spreading.
Bcl-2 and Bax are members of the group of proteins that regulate the apoptotic pathway. Sinicrope et al (1995) demonstrated that colorectal carcinomas with a high percentage of cells expressing Bcl-2 were significantly more likely to have low AIs than those with low or absent Bcl-2. We previously indicated that in Bcl-2-positive gastric carcinomas the apoptotic labelling index is significantly lower in Bcl-2-positive foci than in Bcl-2-negative foci, and the majority of Bcl-2-positive cancer cells were in a nonproliferating state using double immunostaining for Bcl-2 and Ki-67 (Saegusa et al, 1995b) . However, some studies have indicated no dramatic difference in the apoptotic rate between Bcl-2-negative and -positive tumours, suggesting that other control mechanisms might also be involved (Wyllie et al, 1992; Sachs and Lotem, 1993) . Discrepancies could also be due to tumour heterogeneity, tissue specificity and evaluation methods for determining apoptosis or Bcl-2 immunoreactivity.
It has been demonstrated that Bax acts as an accelerator of apoptosis, opposing Bcl-2 effects on cell life (Oltvai et al, 1993) . Krajewski et al (1994) proposed that the ratio of Bax to Bcl-2 plays a critical role in regulating the relative propensity for apoptosis. Recently, we demonstrated that Bcl-2 may be predominantly expressed at an early stage in gastric carcinomas, possibly in negative association with p53 gene abnormalities . Texieria et al (1995) demonstrated that in human breast cancer cell lines oestrogen (E2) depletion results in a marked decrease in Bcl-2 expression but does not alter bax gene expression, suggesting that, in the absence of E2, the Bax/Bcl-2 ratio is increased. In the present study, the finding that AIs in carcinomas with high Bcl-2 immunolabelling scores were significantly lower than in those with low scores or negative for Bcl-2 particularly in early-stage tumours, in line with the MIs, together with the positive association with Bax immunoreactivity, supports the conclusion that Bcl-2 and Bax are important regulatory proteins in cell life. The possibility of a close linkage between the Bcl-2/Bax coexpression pattern and progression was also demonstrated in uterine cervical neoplasms (Saegusa et al, 1995c) . Although some studies have indicated the presence of mutant type bcl-2 and bax genes (Pietenpol et al, 1994; Meijerink et al, 1995) , further study is needed to clarify their functional significance.
The prognostic significance of Bcl-2 expression in malignant tumours has attracted the attention of several authors. It is apparently correlated with a favourable prognosis in lung (Pezella et al, 1993) and breast cancers (Silvestrini et al, 1994) , while not correlating with pT stage, lymph node status and survival in gastric carcinomas (Lauwers et al, 1995) . In the latter other factors, including depth of tumour invasion, tumour differentiation, lymph node status, venous spread and whether curative or palliative surgery is performed, may play an important role in determining survival rates. Earlier studies have demonstrated that early-stage gastric carcinomas with a high propensity for blood vessel invasion and lymph node metastasis show a worse prognosis because of early post-operative hepatic metastasis (Kodama et al, 1983; Orita et al, 1992) . Recently, Ranaldi et al (1995) reported that in large early gastric cancers the presence of submucosal penetration and lymph node metastasis shows a highly significant association with a lower survival rate.
Considering the high incidence of AIs and MIs in the present advanced-stage lesions, a possible relevance of apoptosis as prognostic factor might have been expected. In our clinicopathological analysis, however, a favourable prognosis was clearly associated with an early stage and an absence of lymph node metastasis, whereas no correlation with the Al, MI or expression of Bcl-2 and Bax was revealed. In addition, lymph node status was not linked with Al and MI values or Bcl-2/Bax expression, even in the advanced category. We therefore speculate that the frequency of apoptosis may not directly reflect biological behaviour, although we cannot draw firm conclusions because of the relatively small number of cases examined. Shepherd et al (1988) showed no correlation between Ki-67 scores and known prognostic parameters in colorectal carcinomas, suggesting that the proliferative status has no influence on the prognosis after surgical treatment alone.
In conclusion, the present study demonstrated that in gastric carcinomas the propensity for apoptosis is closely associated with cell proliferation and expression of Bcl-2 and Bax, but this appears unlikely to have any important value as a prognostic factor.
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